Search

everythinglearnresearchcommunity

for

Search:↓

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

MAFT is a reliable method for forehead contouring with high patient satisfaction and long-term results.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Erbium glass laser treatment may help with skin remodeling, reduce inflammation, and improve skin cell maturation.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Aromatic plants can naturally help prevent skin aging and improve skin health.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

HPV vaccines are generally safe but need further investigation for rare side effects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

NGAL may help maintain skin balance and is linked to skin disorders and cancers.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

PSU are better than THF at regenerating skin layers in lab models.

Some chemicals absorbed through the skin can cause serious health problems.

Hair casts and cutaneous spicules can be signs of multiple myeloma.

Leucaena leucocephala is nutritious but needs careful processing to remove toxins.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Finasteride exposure harms tadpole reproduction and hormone balance.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.